Transcranial magnetic stimulation as a new therapeutical approach in autism spectrum disorders and attention deficit hyperactivity disorder – a review

Skrócona strona pozycji
dc.contributor.authorSavino, Rosa
dc.contributor.authorPolito, Anna N.
dc.contributor.authorVentriglio, Antonio
dc.contributor.authorBellomo, Antonello
dc.contributor.authorMoscatelli, Fiorenzo
dc.contributor.authorPolito, Rita
dc.contributor.authorValenzano, Anna A.
dc.contributor.authorMessina, Giovanni
dc.contributor.authorCibelli, Giuseppe
dc.date.accessioned2023-03-10T20:16:58Z
dc.date.available2023-03-10T20:16:58Z
dc.date.issued2023-03
dc.description.abstractIntroduction and aim. Autism spectrum disorders (ASD) and attention deficit hyperactivity disorder (ADHD) neurobiology reveals a complex picture of altered excitation-inhibition balance, aberrant neuronal and neurotransmitter activity, and network disorganization that could be addressed through repetitive transcranial magnetic stimulation (TMS). In this paper, we provide a narrative review of the most recent literature on the use of TMS to treat patients with ASD and ADHD. Material and methods. Literature search from 2018 up to November 2022 has been conducted on PubMed database. Keywords reflected diagnoses and treatment modalities of interest. Analysis of the literature. Eleven clinical trials regarding the use of TMS as a therapeutic tool in ASD, and seven studies (of which 3 are case reports) for ADHD have been reported. The dorsolateral prefrontal cortex (DLPFC) is the most frequent area stimulated. Heterogeneity in stimulation parameters, patient age, and outcome measures limited the interpretation of findings. Conclusion. TMS as a therapeutic tool for neurodevelopmental disorders is still in its infancy. To define the real efficacy of TMS, future studies must be randomized, sham-controlled, and double-blind, and should include a larger sample with adequate inclusion/exclusion criteria, and longitudinal follow-up.eng
dc.identifier.citationEuropean Journal of Clinical and Experimental Medicine T. 21, z. 1 (2023), s. 133-144
dc.identifier.doi10.15584/ejcem.2023.1.17
dc.identifier.eissn2544-1361
dc.identifier.urihttps://repozytorium.ur.edu.pl/handle/item/8803
dc.language.isoeng
dc.publisherPublishing Office of the University of Rzeszow
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Poland*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/pl/*
dc.subjectADHD
dc.subjectASD
dc.subjectautism
dc.subjectneuromodulation
dc.subjectneurodevelopmental disorders
dc.subjectTMS
dc.titleTranscranial magnetic stimulation as a new therapeutical approach in autism spectrum disorders and attention deficit hyperactivity disorder – a review
dc.typearticle
Pliki
Oryginalny pakiet
Aktualnie wyświetlane 1 - 1 z 1
Obrazek miniatury
Nazwa:
17.Savino_in-Transcranial_magnetic_stimulation_as_a_new_therapeutical_approach.pdf
Rozmiar:
291.81 KB
Format:
Adobe Portable Document Format
Opis:
Pobierz
Pakiet licencji
Aktualnie wyświetlane 1 - 1 z 1
Obrazek miniatury
Nazwa:
license.txt
Rozmiar:
1.28 KB
Format:
Item-specific license agreed upon to submission
Opis:
Pobierz
Kolekcje
European Journal of Clinical and Experimental Medicine T.21, z. 1 (2023)